REQUEST A DEMO
Total
USD $0.00
Search more companies

Bosnalijek d.d. (Bosnia and Herzegovina)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bosnalijek d.d. Profile Updated: April 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bosnalijek d.d. is the largest pharmaceutical manufacturer in Bosnia and Herzegovina, founded in 1951. The company is focused on its customers and aims to enrich its product range every year with new products tailored to their needs. The company's production program is focused on drugs for mass therapeutic use. It includes drugs for oral, parenteral, and topical use, with effects on the digestive system and metabolism, cardiovascular system, systemic infections, skin, musculoskeletal, nervous and respiratory system, as well as systemic hormonal drugs, excluding sex hormones. In addition to drugs, the company's product range also includes dietary supplements and disinfectants for medical and general use. Bosnalijek is strategically focused on improving the quality of its business and production processes. Continuous improvement, careful analysis, and meticulous planning are the fundamental principles of their operations. The company's development is based on the modernization of facilities, employee education and continuous improvement, and alignment with global pharmaceutical standards. Bosnalijek is committed to consistently applying quality in all business operations and processes, producing high-quality drugs, and positioning itself as an internationally competitive pharmaceutical company. The company's quality system fully complies with national and international laws and Good Manufacturing Practices standards, meeting the expectations of customers, partners, and regulatory bodies. Bosnalijek demonstrates its interest and care for the development of Bosnian society by supporting projects and events in the fields of culture, sports, science, and education. They particularly encourage education and have successful collaborations with pharmaceutical, medical, and natural science faculties, sponsoring the work of young talented students and scientific achievements in the field of medicine and pharmacy. They actively support professional and scientific conferences and the participation of Bosnian experts in international events.

Headquarters
Jukiceva 53
Sarajevo - Center; Sarajevo; Postal Code: 71000

Contact Details: Purchase the Bosnalijek d.d. report to view the information.

Website: http://www.bosnalijek.ba

Basic Information
Total Employees:
Purchase the Bosnalijek d.d. report to view the information.
Outstanding Shares:
Purchase the Bosnalijek d.d. report to view the information.
Registered Capital:
Purchase the Bosnalijek d.d. report to view the information.
Financial Auditors:
Purchase the Bosnalijek d.d. report to view the information.
Incorporation Date:
January 01, 1951
Key Executives
Purchase this report to view the information.
Chairman of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
23.67%
Purchase this report to view the information.
19.02%
Purchase this report to view the information.
13.62%
Purchase this report to view the information.
7.6%
Company Performance
Financial values in the chart are available after Bosnalijek d.d. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BAM. Absolute financial data is included in the purchased report.
Net sales revenue
-8.65%
Total operating revenue
-15%
Operating profit (EBIT)
-47.69%
EBITDA
-38.62%
Net Profit (Loss) for the Period
-17.03%
Total assets
3.02%
Total equity
0.63%
Operating Profit Margin (ROS)
-10.64%
Net Profit Margin
-0.68%
Return on Equity (ROE)
-1.21%
Debt to Equity Ratio
1.3%
Quick Ratio
-0.23%
Cash Ratio
0.02%

Similar companies

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?